Next-generation ‘anti-cancer weapons’ to be developed in innovative partnership between Randox and Transgene
Randox Laboratories has today announced an innovative European partnership with French biotech company Transgene, which aims to develop a game-changing therapy for cancer treatments.
It involves cutting-edge technology and ‘anti-cancer weapons’ in the form of oncolytic viruses which directly target and destroy the cancer cells, and also deliver antibodies in the tumour microenvironment to further attack the rest of the tumour. This has clear advantages over traditional treatments such as radiotherapy and chemotherapy which as well as targeting cancer cells, can affect healthy cells.
In addition, if successful, this therapy will address the efficacy challenges faced by either Oncolytic viruses or Check-point inhibitors’ neutralization used independently, as their combination is expected to trigger a sustained anti-tumoural immune response from the patient.
The partnership will bring together Randox’s unique collection of therapeutic single domain antibodies (sdABs), which are on the front line in the fight against cancer, and Transgene’s next-generation viral platform Invir.IO™.
Commenting on the agreement, Dr. Peter FitzGerald, Managing Director and Founder of Randox Laboratories, said:
“This collaboration will enable ground-breaking innovation and research to be carried out in a critical area of human health. The work we will be doing in the field of cancer treatment has an enormous potential benefit for patients through the delivery of more effective treatments. We are looking forward to working with Transgene to generate oncolytic viruses that will be able to deliver single and multiple payloads directly into the tumour, enhancing their efficacy. This partnership will allow us to better leverage our SdAb capabilities and immuno-oncology expertise, and add to our strategic collaborations across the world.”
Eric Quéméneur, PhD, Executive VP and VP Research & Development of Transgene, said:
“We are delighted to collaborate with Randox. Its library of SdAbs against major targets in immuno-oncology provides an excellent opportunity to demonstrate the high potential of our Invir.IO™ platform. We look forward to working with Randox and to generating novel product candidates which combine the merits of oncolytic virotherapy and local delivery of therapeutic payloads. We believe such targeted expression of therapeutic agents including immune checkpoint inhibitors will better potentiate the tumour microenvironment and paves the way for the development of a broad range of innovative cancer treatments.”
For further information about Randox’s collaboration with Transgene, please visit our Randox Biosciences website. Click here.
If you have any additional questions please contact Randox PR by phoning 028 9442 2413 or emailing RandoxPR@randox.com
Randox Presence at China’s Largest Laboratory Equipment Exhibition Signals Continuation of Growth in Chinese Market
Global health diagnostics provider Randox has maintained its status as a significant competitor in the Asian market by participating in the NCML Exhibition in Hangzhou. The NCLM is the largest laboratory equipment exhibition in China dedicated to the advancement of diagnostic equipment and is an annual staple of the country’s top medical equipment firms. Also attracting some of China’s top clinical science talents, the exhibit was held in the capital of China’s Zhejiang province on 20th September.
In-vitro diagnostic (IVD) equipment, which enables diagnosis and monitoring of samples taken from the body, was the sole focus of the exhibition but an essential aspect of the IVD process is Quality Control. The Quality Control Market is a lucrative one and continues to grow – estimated to be worth $1.04 billion by 2022.
Over many years, Randox has developed the largest global EQA (External Quality Assurance) scheme available on the market, RIQAS, which offers laboratories around the world assurance that the results they are releasing are accurate and reliable. With just under 40, 000 participants in 132 countries and 32 flexible programmes, it is little wonder that the global health technology giant is predicting huge growth in Chinese territories.
Randox has been involved in trade in China for over 20 years and has been making significant strides in the Asian market recently through a strategic Chinese market expansion launch in December 2016. This expansion has included the securing of distributors across four of the largest provinces in China and partnerships with hospitals in Guangzhou, Shanghai and Wuhan.
Preceding the NCML Exhibition, in February 2017, Randox launched a major recruitment drive to hire Mandarin-speaking graduates in Northern Ireland who could join the sales, marketing and scientific teams in China. The company, which employs over 1,400 workers worldwide, was supported by Ulster University and its Confucius Institution in this recruitment campaign.
Ying Zhu, Sales Manager for Randox Laboratories in China, commented on the success Randox has seen in China over the last ten months;
“China is one of our key markets and we were delighted to showcase our capabilities at China’s largest IVD equipment exhibition recently. Randox in China has been growing from strength to strength in the last year, building on a solid foundation laid in 20 years of trade with the country. We continue to increase our presence in the Asian market thanks to increased output from our innovative R&D programmes, and enhanced manufacturing capabilities, including new facilities at the Randox Science Park, our new headquarters in Antrim. These infrastructural developments have resulted in an increasing range of products which we can now offer to growing and dynamic markets such as China. This increasing range of products coupled with a growing market presence has significantly increased our business penetration and subsequent support to customers.”
Margaret Fick, RIQAS Scientist added;
“At our most recent training conference in China, we were very pleased to host several of our newly acquired hospital partners who presented to our audience how many laboratories have benefitted from our Randox Quality Control products. The testimonials from high profile individuals who have experienced the quality, efficiency and reliability of our products is accelerating our growth across China. Our inclusion at the NCLM Exhibition marks another cornerstone in Randox’s expansion in China.”
For further information about NCLM, please contact Randox PR by phoning 028 9445 1016 or emailing RandoxPR@randox.com
Randox Food Diagnostics harnessing science of antibiotic screening to ensure safer honey
Global leader in food screening technology, Randox Food Diagnostics have developed a range of pioneering honey quality tests which are being adopted by apiculturists across the world to ensure the safety and quality of their produce.
The array of tests, developed by the Antrim-based firm, are being showcased this week at the world’s largest apiculture meeting, the Apimondia International Conference, being held in Istanbul, Turkey from September 29th to October 4th.
The company hopes to highlight to consumers and producers about the importance of food safety, and in particular the dangers of antibacterial residue in food. Scientists have warned that antibiotics used in food production, are passing through the food chain to consumers and therefore contributing to the rise in infections caused by antibiotic-resistant bacteria.
Randox Founder and Managing Director, Dr Peter FitzGerald, commented;
“As a company committed to supporting the fight against antibiotic resistance we must continue to drive awareness amongst producers and consumers alike.
“We are working closely with industry to promote a responsible approach to antibiotic use in food production and we hope that by working with some of the biggest names in the apiculture market, other honey producers will see the benefits of being able to offer their customers complete consumer confidence in a high quality, and importantly, safe product.”
At Apimondia 2017 Randox Food Diagnostics will showcase a range of major technological advancements including the firm’s Antimicrobial Array 1 Ultra, Antimicrobial Array II Plus and Antimicrobial Array V. Thanks to Randox’s patented Biochip Array Technology, these testing panels can simultaneously screen for multiple antibiotics that are sprayed on beehives to ensure the safety of the colony, from only one sample of the produce.
Randox Food’s Antimicrobial Arrays join the company’s already extensive menu of honey screening tests, including its test for Hydroxymethylfurfural (HMF), a test for an organic compound produced by dehydration of sugars, which can be indicative of overheating, poor storage conditions or aged honey. The test was recently validated by leading South American honey producer Geomiel, which credited Randox Food for delivering an immediate improvement in the quality of its honey products.
David Ferguson, Global Business Manager for Randox Food Diagnostics, commented;
“We welcome the fact that so many of the world’s leading producers, including Geomiel, have embraced our vision of continuously improving testing standards.
“We have invested a lot in simplifying the process of conducting multiple tests, and consolidating this onto one unique biochip is a cost-effective way for the honey industry to maintain and improve standards. Apimondia 2017 attendees will be offered a complete testing bundle – including our popular analysers, the Randox Evidence Investigator and RX misano, to enable them to test for antibiotics and assess quality in one easy-to-manage system.
“Another unique feature of what we offer here at Randox Food Diagnostics is our ever-expanding test menu. The RX misano for example has a customisable test menu which allows clients to upload new parameters using USB, ensuring access to the most up-to-date tests on the market.
“We will be inviting Apimondia guests to learn more about the upcoming launch of our new pesticide tests, which will provide multiple results for the world’s most prevalent pesticides, such as Amitraz, Acetamiprid, Carbofuran, Carbaryl, and Paraquar. We remain committed to supporting food producers by providing them with the newest and highest quality tests.”
For further information about Randox Food Diagnostics honey testing, please visit: http://www.randoxfood.com/Matrices/Honey
For any further questions please contact Randox PR by phoning 028 9445 1016 or emailing RandoxPR@randox.com
Heart attack test H-FABP 12 times faster than current methods
As the supplier of a pioneering diagnostic able to assist with differentiating between coronary pain and non-cardiac chest pain, Randox Laboratories has this week welcomed news about the importance of introducing new innovations which can significantly improve patient outcomes.
Prioritising people presenting with a heart attack over those with non-cardiac chest pain is one of the biggest challenges A&E doctors face – there are around 200,000 heart attacks each year in the UK, but around 1 million people come to A&E with chest pains. According to a team from King’s College London, as reported by the BBC, a faster, more accurate diagnosis of whether chest pain is caused by a heart attack would save the health service millions of pounds each year by sending well patients home and freeing up beds. Yet current testing methods do not efficiently differentiate between high-risk patients and the estimated 80% of patients who are not having a heart attack.
Randox’s revolutionary test for Heart-Type Fatty Acid-Binding Protein (H-FABP) however, when combined with current testing, is able to rule out a heart attack for patients who present at A&E with chest pain which is caused by other conditions such as respiratory issues, meaning they may not need emergency admission.
When measured at the time a patient presents to A&E with chest pain, H-FABP enables doctors to triage patients suffering with a heart attack more efficiently than before.
Dr. Gary Smyth, Medical Director at Randox Laboratories, hopes that more efficient testing will become widely available so that doctors can identify and prioritise patients at risk;
“Despite the best efforts of our NHS colleagues, EDs across the UK are under tremendous pressure. In many cases people are presenting with chest pain but aren’t suffering from a heart attack, and given that current cardiac tests are not as sensitive as clinicians would like, these patients are being admitted unnecessarily, taking up beds and valuable resources.
“It is imperative that newer, faster tests are adopted because fundamentally this means saving lives.”
H-FABP is released into the bloodstream within 30 minutes of a heart attack, whereas people who are currently admitted to hospital with chest pains may have to wait several hours for test results. Even the latest heart attack test to be adopted by the NHS, troponin, can take up to six hours to provide confirmation.
H-FABP, conversely, is released from the heart during the early stages of a heart attack and because it is so small, it can be detected when the heart cells are being damaged, rather than at the stage when troponin would usually be detected – when cell death has already occurred. The test can also be used to identify people who are at high risk of heart attack in the near future.
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“Research shows that patients who were troponin negative and therefore sent home from hospital, but who were positive for H-FABP, were at high risk of death – as high as a 20% chance of death that same year.
“If the H-FABP test was added to existing tests upon arrival at hospital, doctors could quickly and accurately rule out the 80% of chest pain patients who are not having a heart attack, allowing resources to be focused on those who are actually at high risk.”
For further information on H-FABP, please visit http://www.randox.com/h-fabp/, or contact the Randox PR team by phoning (0) 28 9442 2413 or emailing randoxpr@randox.com
World Heart Day – 29th September 2017
World Heart Day – 29th September – Introduction
This year (29th September 2017) join us as we help to raise awareness for World Heart Day! The theme for this year’s World Heart Day is to share the power – and you know what they say… “Knowledge is Power” so throughout this blog we will be providing vital knowledge as well as tips to having a healthy heart!
The heart is a muscular organ that pumps blood around the body and is indeed central to your circulatory system. The system consists of a network of blood vessels, including, veins, arteries and capillaries. These vessels transport blood – as well as carrying oxygen and other important nutrients – to every part of the body. Ensuring a healthy heart is therefore vital.
What is CVD?
When too much pressure is put on our hearts we start to run into some issues – the general term for conditions affecting the heart is Cardiovascular Disease – better known as CVD. The exact cause of CVD is far from clear, with many factors increasing your chances of developing CVD. These risk factors can include, but are not limited to, high blood pressure, smoking, high cholesterol, being overweight or in many cases, can be hereditary.
It is important to note that Cardiovascular Disease is accountable for nearly half of all non-communicable disease (NCD) deaths, therefore making it the number one killer across the globe! Scary thought considering there are a whopping 17.3 million CVD related deaths per year – including stroke and heart disease. Understanding CVD in today’s society is more important than ever before, we need to know the truth about CVD and be able to decipher the facts from the fiction. Below you can see a few examples of common misconceptions regarding CVD and also some that are indeed true.
Only older men can get heart disease/CVD
False
Cardiovascular Disease can develop before birth
True
Exercising won’t help if you’re genetically predisposed to CVD
False
Low and middle-income countries are the most susceptible to CVD
True
It is estimated that by 2030 the number of deaths, due to CVD, will rise to an enormous 23 million globally! However, by raising awareness of the critical numbers and facts we can all help prevent CVD by making small, simple lifestyle changes.
Tips for a Healthy Heart
Using our “art into heart” graphic below, we decided to outline some of our Randox QC top tips for staying healthy! Why not try some of them and feel the effects of having a happy, healthy heart!
This World Heart Day, join us and many more around the world, to raise awareness for this great cause and unite together to “Share the Power”.
Ulster GAA team sponsored by Randox bringing sporting excellence to China
Ulster University’s GAA team is preparing to travel to China on an historic tour of the country as part of the university’s wider programme of engagement in key international markets.
The trip, which will be sponsored by Crumlin-based diagnostics firm Randox, will see a 35 strong team depart on 28 October for a two week cultural exchange that aims to develop and enhance links with a number of Chinese academic institutions.
The team will travel to Beijing, Wuhan, and Huangshi City and play several games as part of an extensive tour promoting sporting excellence at Ulster University and Gaelic Games in particular.
Professor Ian Montgomery, Pro-Vice Chancellor, Global Engagement at Ulster University said:
“GAA is of increasing interest to the Chinese people and there is a strong appetite to learn about the various sports, key tactics and the strong cultural identity which Ulster University’s GAA team has developed over many decades. This tour, supported by Randox, will give our team the opportunity to showcase Gaelic football and hurling to a vast audience which is interested to learn more and experience a game first-hand through a number of Gaelic Games masterclasses.”
“As an internationally focused university it is important to continually build new partnerships in this vast market and further enhance existing linkages. From research collaborations with some of China’s top universities to our role as home to the Confucius Institute and Confucius classrooms initiative in Northern Ireland, China remains a significant market with clear potential for growth. We look forward to building on our work in this region and meeting new connections as part of the tour.”
Dr Peter FitzGerald, founder of Randox, said:
“We are pleased to support Ulster University’s Gaelic team as they embark on a very exciting tour of China. It is one of our most important markets, as we have been exporting to China since 1992 and we have had an established presence in the region for several years. This is a brilliant opportunity for our partnership with Ulster University to profile some of the young sporting talents of Northern Ireland and to strengthen key business relationships in an important market.”
For further information about the Randox-sponsored GAA tour, please contact Randox PR by phoning 028 9445 1016 or emailing RandoxPR@randox.com
We Are Randox | Cristina Zenha in Randox Portugal celebrates 25 years with us
What makes Randox the successful, innovative and forward-thinking company it is today are the passionate, hard-working and talented staff we’re lucky enough to call our colleagues.
Our staff are our best asset and across every division our team help to save lives – whether it be designing the newest Biochip to test for Alzheimer’s disease, developing the latest software for use in hospitals and universities, making food safer for people to eat, or managing our global offices, to ensure our pioneering health technologies make their way across the world to where they are needed the most.
Our headquarters are in Northern Ireland, but we have teams based all over the world, including in Portugal, where Cristina Zenha works as part of the Portuguese Finance Team.
2017 is a special year for Cristina. It marks 25 years since she began her job with Randox.
We sat down with Cristina to ask her about her time with us, to find out how she thinks the company has changed during that time, and of course to congratulate her on her exciting milestone!
Here’s Cristina’s story.
My name is Cristina Zenha and I work in the Finance team in Randox Portugal in Oporto.
For those of you who don’t know the area, the weather is very good here in Oporto. It’s not very cold in winter, nor is it very hot in summer. It’s just right! During the summer I love going to the Algarve for my holidays. There are beautiful beaches and the weather is excellent, so it’s a very popular holiday destination for both the Portuguese and for tourists.
In Portugal, Randox is based in Oporto City, which as one of the oldest tourist destinations in Europe, has a wonderful artistic heritage. The Port Wine, the vast spaces dedicated to leisure and culture, and the relaxed way of life are just some of the reasons I would recommend visiting the city!
We also have excellent cuisine here in Portugal. Seafood is very popular and we have several famous cod recipes. In Oporto specifically, we have a very famous dish called Francesinha, which is a Portuguese sandwich made with bread, ham, fresh sausage and steak, covered with melted cheese and a hot thick tomato and beer sauce, and served with french fries.
Before I moved into the world of full-time work I worked in my parents’ grocery store, which sparked my interest in business. Then I began my first serious job in Randox Portugal when I was only 19 years old, and studied part-time Business Management in Oporto Lusiada University. I took my university classes in the evening to work around my job with Randox.
When I had my interview I had a really good feeling about Randox. I could tell that this company, which was only just beginning to establish itself in Portugal, was going to go far. I could see myself developing both personally and professionally in what was evidently a globally successful organisation. I knew I would learn a lot.
When I started my job with Randox in Oporto I was involved in processing orders, documenting stock, and organising customer invoices and receipts. However in the 25 years I’ve worked here, my job, and the office itself have evolved and changed. My current responsibilities have progressed to additionally include office finances and accounts, and I also manage the logistics of our site.
How we work in the team has also changed drastically. I remember when I first started in 1992 there were no computers so everything was done manually. I had a typewriter to make invoices, receipts and letters. We created manual maps for everything and we updated everything manually.
The team itself has more than doubled in size, in spite of a number of economic crises in Portugal during that period. The infrastructure in Randox, and its offering of highly innovative diagnostics has meant that demand for our products has continued to increase. We have a fantastically passionate team in place who all want to see the business succeed and everyone works together to bring next-generation healthcare to hospitals and laboratories across Portugal.
I think that’s one of the reasons I love my job so much. Each member of the team here has an important role to play and we each contribute to Randox’s vision of saving lives. It’s fast-paced and challenging, but that’s what I love. I like the structure in place and I enjoy the satisfaction that comes with resolving issues and contributing to increased sales and overall business success. I can’t wait to see what the future holds for Randox. I know that the company will continue to grow and succeed and I feel privileged to be involved in its journey.
I want to say a big thank you to everyone with whom I have worked during my 25 years here at Randox. I love everyone I work with and you are such a big part of why I have loved my time here so much. I want to say a big thank you in particular to Bob Allan in Finance, who was one of the first people I met in Randox. He has always been on hand to support the work we do in the Portuguese office, and the way in which he made me feel so welcome and supported will always be one of my favourite memories of my first 25 years working in Randox.
Here’s to the next 25!
Cristina
Congratulations Cristina on your 25 year milestone with us here at Randox. You are a real asset to our global healthcare company and we are delighted to have you as part of our team!
For more We Are Randox stories about our amazing colleagues, make sure to follow us on Facebook, Instagram and Twitter and follow the hashtag #WeAreRandox.
For current vacancies in our team, visit careers.randox.com
Randox pledges support for PSNI in the fight against fentanyl
Global drug tests provider Randox Toxicology has today pledged its support for the PSNI in the fight against fentanyl, a strong painkiller which has been found for sale on the black market in Northern Ireland for the first time.
Fentanyl, which is an opioid pain medication currently classed as a controlled Class A drug under the Misuse of Drugs Act 1971, has been found in heroin which was seized by the PSNI, and has been linked to two deaths in Northern Ireland this year.
It is currently used to safely treat patients with severe pain, as it can be 50 to 100 times more potent than morphine. According to the National Crime Agency and Office for National Statistics however, 60 deaths in the UK in the past eight months have been attributed to misuse of fentanyl, which received international attention when the singer Prince was found to have died from a fentanyl overdose.
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“It is extremely worrying to hear that the PSNI have confirmed fentanyl has reached the black market in Northern Ireland. The illegal sale of the painkiller has long been an issue in the USA, with the country having at least two million opioid addicts, but until now has not been used illegally in NI.
“Fentanyl’s status as a painkiller is potentially why it is so commonly abused, as those using prescription painkillers may turn to illicit substances, such as fentanyl, when their prescriptions run out. With as little as 2mg able to cause an overdose, fentanyl is easily hidden and transported in small packages through the post, so poses a major danger to society. The drug has high abuse potential and is being used more and more by drug dealers who can sell fentanyl at a cheaper price than heroin.”
Randox Toxicology, a specialist division of FitzGerald’s Antrim-headquartered Randox Laboratories, has today issued a statement to pledge its commitment to removing the danger of fentanyl from Northern Ireland. The company’s significant investment in the research and development of new tests for drug detection has cemented its status at the forefront of the drugs screening industry. Randox Toxicology, which developed its first fentanyl test in 2007, has the world’s only tests for the designer opiates U-47700, MT-45 and AH-7921.
Dr. Joanne Darragh, Head of Research and Development at Randox Toxicology, commented;
“In the endless pursuit of creating innovative tests for new drugs which emerge weekly on to the market, our expertise at Randox Toxicology sets us apart from the rest of the industry. Not only have we been first to market with a number of opioid tests, but we have also developed our patented Biochip Array Technology, which enables us to simultaneously screen for both fentanyl and heroin, one of which may have been laced with the other.
“Today we pledge the support of our expertise, based on a decade’s worth of experience in developing fentanyl tests, to the PSNI in their efforts to remove the fentanyl threat from Northern Ireland. This is a problem that we must tackle together and we are confident that by highlighting this growing epidemic, we can educate communities on the devastating effects the misuse of fentanyl can have.”
For further information about Randox Toxicology’s fentanyl screrening please contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
Randox Polo Tournament returns to Bushmills
Hot off the heels of its first ever Randox Health Grand National, global healthcare company Randox returned this weekend to Bushmills to again host its International Polo Tournament. Renowned polo players from across the world joined the founder of the Co Antrim-based firm, Dr Peter FitzGerald, to play in the coastal town.
Following a successful event last year, which was the first of its kind held in Northern Ireland, the 2017 Randox Polo hosted almost 450 guests, including Lord-Lieutenant of County Antrim, Mrs. Joan Christie OBE, and Mayor of the Causeway Coast and Glens Borough Council, Joan Baird, who delivered the match ball of the first polo game. Former Miss Northern Ireland and fitness blogger Tiffany Brien, added a touch of glamour to the event.
On display was the company’s latest venture – the Randox Health Mobile Clinic. The unveiling of the bespoke Mercedez-Benz vehicle marks a departure from traditional models of healthcare provision, as the company’s advanced health screening programmes are now available to people anywhere in the country, using its travelling team of trained scientists and phlebotomists.
It was a victory for the Randox team in their first game of the tournament, as they went head-to-head with Scotland, but it was the Republic of Ireland team who emerged winners of the International Polo Tournament when they scored more goals than Team Randox in the final match of the day.
Randox, a recognised supporter of the arts, launched the weekend with a performance from Camerata Ireland Cameratino, an ensemble composed of acclaimed Irish flautist Eimear McGeown, and a String Trio including Violinist Sarah Sew, Violist Nathan Sherman and Celloist Gerald Peregrine, in Dundarave Estate.
The musical element continued on Saturday with a Beating of the Retreat by the Royal Irish Regimental Band, including the highly popular “Highland Cathedral,” and a unique version of “Run” by Snow Patrol.
Local Bushmills residents weren’t put off by the wet conditions, and turned out to watch both the polo tournament, and the fireworks display which rounded off the event.
Randox Founder and Managing Director, Dr. Peter FitzGerald, a keen horseman who played in the polo tournament, commented;
“Given that our inaugural tournament in 2016 received such positive feedback from the Bushmills community, we are delighted to have been able to once again bring the event to the beautiful North Coast and its residents, and to bring the Randox Health message to our Polo guests. By prioritising your health and wellbeing you can make the most of life’s special moments and occasions – like this great polo tournament.
“We’re very lucky that the resilient spirits of the local Bushmills community weren’t dampened by the rain, and everyone was able to enjoy a wonderful afternoon together on the beautiful north coast.”
For more information about the Randox Polo Tournament in Bushmills contact the Randox PR team: Call 028 9442 2413 or email randoxpr@randox.com
We Are Randox | Randox Apprentice Grace Catney graduates with First Class Foundation Degree
Did you know that in partnership with Southern Regional College, Randox offers an industrial apprenticeship scheme?
This month our first group of Randox apprentices completed this Foundation Degree in Applied Industrial Science, and we’re delighted to announce that Grace Catney, an apprenticeship from our Quality Control division, has graduated with a first class degree!
We sat down for a chat with Grace to find out how she has found the apprenticeship experience, and what she wants to let students know about what it’s like to do an apprenticeship with Randox.
This is what Grace had to say:
After completing one year of my A-levels I applied for a BTEC National Diploma in Applied Science, having realised that doing A-levels wasn’t the path I wanted to take. For young students I think it’s so important to let them know that there is no one correct path to your dream job. Going directly into university isn’t for everyone, and completing the National Diploma was the best decision I made for my own education, as I gathered the hands on experience in the laboratory that I wouldn’t have had if I was to finish my A levels. During my National Diploma which lasted 2 years, I worked in my family’s chip shop and in Starbucks, which was also so fundamental in teaching me how to balance work, education and leisure.
Then when I gained a Triple Merit in my BTEC, my tutor from Southern Regional College made me aware of the apprenticeship with Randox, and so I went along to an interview which lasted around 20-30 minutes. Four people were chosen to take part in the apprenticeship programme, with three out of the four people having been on the BTEC course with me. The other apprenticeship came from a previous job and already had a masters degree. The apprenticeship programme is open to people from all walks of life.
The apprenticeship itself is a 2 year programme made up of one day a week in the Southern Regional College in Portadown, and four days a week working in Randox. At college I studied a range of modules including Biochemistry, Genetics, Professional Practice, Laboratory Procedures, Physiology, Cell Biology, Chemistry and Mathematical Statistics, and at Randox I completed 3 rotations working within Production, Biochip Quality Control and R&D Quality Control.
Carrying out the apprenticeship has helped me improve so much in many areas. Working and completing the Foundation Degree is very intense, as you are simultaneously studying for exams and learning new work skills within your department. But the benefit is that you can apply what you are being taught to your work as soon as you learn it, which makes understanding the concepts so much easier.
The most enjoyable part of the apprenticeship was the rotation through different departments. This helped me to learn a lot about the work that goes on – from the initial production of a Reagent, to Microbiology, Quality Control, Quality Assurance and then shipping to customers. Being in multiple departments has allowed me to see different stages along the production life of a product, while getting to know many incredibly talented employees throughout the company.
Working for such a globally successful company has given me the opportunity to see how science is changing the world, and to be a part of it, and it has also given me an advantage over full-time university students, because I already have 2 years’ experience in the science industry and a job secured. Education is important, but in the science industry experience is essential, and that’s what I am thankful to Randox for.
I have been treated as an employee, and not just a student. The responsibilities with which my managers have entrusted me with have given me a real insight into the role of an analyst, and the different rotations helped me to determine what area of science I would prefer to work in.
When I came into Randox all I knew is that I wanted a hands-on, practical job that would help make a difference in the world of healthcare. When I completed my final rotation in R&D Quality Control, I knew that it was the department I could see myself in permanently, and so I was delighted when I was offered a full time job.
Knowing that my work over the past few months in Quality Control has been to a level high enough to be offered a permanent job is a very good feeling. Many students come out of university with a degree but cannot find a job. I’ve done the opposite of that in some ways – I secured a job first before moving on to the next stage of my degree! The only condition of the job was that we had to pass the foundation course, and so luckily I got a first overall.
I feel a mixture of nerves and excitement knowing that I’m going to be completing my final two years of a BioMed degree while working at Randox. I think the distance learning will be an easier transition than maybe I had previously thought, given that during the apprenticeship we only had one day in class and had a lot of online classes throughout the week. I’ve never wanted to go to university as a full time student and so I’m am glad that this is available to me to complete while continuing my career with Randox. I have read a lot about the Biomedical Degree and the modules and am quite eager to begin the course.
It’s also reassuring knowing that over the past 2 years I have significantly developed my ability to prioritise work, and to balance my job and studies. This will set me in good stead for my BioMed degree. Having a full time job and completing coursework and studying for exams is very hard and can be stressful – but the end result is worth it.
It can be challenging, but that’s what I love about science – there are so many new reactions, materials, procedures, regulations etc. to learn. There can be a big workload at times, but that’s always going to happen when you’re part of such a fast-paced company, and at Randox we’re very lucky that the support is always there if needs be. Luckily, I enjoy the rush and challenge of my job, and knowing your employer is trusting you to work on their world-class products is an amazing feeling.
Although the apprenticeship is challenging, if you have the right mind-set and motivation, you will gain so much from it. I highly recommend the Randox Higher Level Apprenticeship Foundation Degree in Applied Industrial Science.
Grace
We wish Grace and her fellow Randox apprentices the best of luck on whatever path they have chosen to progress to the next stage of their careers.
For more We Are Randox stories about our amazing colleagues, make sure to follow us on Facebook, Instagram and Twitter and follow the hashtag #WeAreRandox.
For current vacancies in our team, visit careers.randox.com
